The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Wattle Health Australia (WHA) is looking to tap investors for $2.9 million by offering up a one-for-12 non-renounceable rights issue
  • Up to 19,220,786 fully paid ordinary shares are up for offer at $0.15 per share in a bid to fuel working capital and accelerate growth
  • WHA affirms it is fully funded to execute its $4.75 million acquisition of Melbourne-based brand development, brokerage and distribution business Brand Solutions Australia announced in April
  • Eligible shareholders will be given an entitlement to subscribe for one new WHA share for every 12 shares held as at the May 18 record date
  • Wattle Health Australia shares have not been traded since February last year

Wattle Health Australia (WHA) is looking to tap investors for $2.9 million by offering up a one-for-12 non-renounceable rights issue.

Up to 19,220,786 fully paid ordinary shares are up for offer at $0.15 per share in a bid to raise the funds, which are tipped to go towards “working capital and accelerating growth”.

Wattle Health said the offer allows existing shareholders to purchase shares at the same price as its previous institutional raise and its Brand Solutions Australia acquisition.

WHA acquired the Melbourne-based brand development, brokerage and distribution business for $4.75 million back in April.

The ASX-lister affirms it is fully funded to execute BSA transaction, maintaining the funds raised under this offer are to accelerate growth.

Eligible shareholders can subscribe for one new WHA share for every 12 shares held as at the May 18 record date, with the offer expected to close on June 7.

Wattle Health Australia shares have not been traded since February last year.

wha by the numbers
More From The Market Online

Candle chain Dusk Group offer “prudent” dividend on back of ACCC lawsuit regarding button batteries

Retail candle store operator

This thinly-traded psychedelic therapeutics stock is up +185% YoY and just clocked record Q1F27 revenue

There’s a handful of companies on the ASX still plodding along with medicinal cannabis products, and, ever to the excitement of risk-on investors,
Wine on a cliff, presumably it isn't windy

Treasury Wine intends to target luxury consumers able to handle shock but trouble still ahead; dividends uncertain

Treasury Wine Estates (ASX:TWE) Chairman John Mullen has issued an address to the market ahead of its AGM at
A Coles storefront.

Coles profit climbs 13% as supermarket sales and online groceries drive growth

Coles has lifted underlying profit 13%, with supermarket sales and online grocery growth offsetting pressure from…